NDC Code(s) : 68220-144-10
Packager : Alaven Pharmaceutical LLC
Category : HUMAN PRESCRIPTION DRUG LABEL
DEA Schedule : none
Marketing Status : New Drug Application
INGREDIENTS AND APPEARANCE
Epifoamhydrocortisone acetate and pramoxine hydrochloride AEROSOL, FOAM | ||||||||||||||||||||||||||
|
||||||||||||||||||||||||||
|
||||||||||||||||||||||||||
|
||||||||||||||||||||||||||
|
||||||||||||||||||||||||||
|
PRINCIPAL DISPLAY PANEL
NDC 68220-144-10
STORE UPRIGHT
epifoam®
(hydrocortisone acetate 1% and
pramoxine hydrochloride 1%)
topical aerosol
Rx Only
ALAVEN®
PHARMACEUTICAL LLC
10 g net wt
PRINCIPAL DISPLAY PANEL
NDC 68220-144-10
STORE UPRIGHT
10 g net wt
epifoam®
(hydrocortisone acetate 1% and
pramoxine hydrochloride 1%)
topical aerosol
Rx Only
HOLD UPRIGHT TO DISPENSE
WARNINGS: Contents of
the container are under
pressure. Do not burn or
puncture the aerosol
container. Do not store at
temperatures above 120°F
(49°C).